Shannon Rourke Devens

Corporate Officer/Principal at SURFACE ONCOLOGY, INC.

Health Technology

Consumer Services

Profile

Shannon Rourke Devens is currently working as the Senior Vice President-Development Operation at Surface Oncology, Inc. Prior to this, Shannon worked as the Senior Director-Clinical Operations at Infinity Pharmaceuticals, Inc. Shannon holds a graduate degree from Northeastern University and an undergraduate degree from the University of Colorado Boulder.

Shannon Rourke Devens active positions

Companies	Position	Start
SURFACE ONCOLOGY, INC.	Corporate Officer/Principal	2021-12-14

All active positions of Shannon Rourke Devens

Former positions of Shannon Rourke Devens

Companies	Position	End
INFINITY PHARMACEUTICALS, INC.	Corporate Officer/Principal	-

See the detail of Shannon Rourke Devens's experience

Training of Shannon Rourke Devens

Northeastern University	Graduate Degree
University of Colorado Boulder	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Shannon Rourke Devens's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
INFINITY PHARMACEUTICALS, INC.	Health Technology

Private companies	1
Surface Oncology, Inc. Surface Oncology, Inc. BiotechnologyHealth Technology Surface Oncology, Inc. operates as a clinical-stage immuno-oncology company, which engages in the provision of biological pathways critical to the immunosuppressive tumor microenvironment for the development of next-generation cancer therapies. The firm’s pipeline includes wholly-owned lead programs targeting CD39 (SRF617) and IL-27 (SRF388), as well as a preclinical program focused on depleting tumor regulatory T cells via targeting CCR8 (SRF114). Its pipeline also includes licensed product programs, such as a collaboration with Novartis targeting CD73 (NZV930, Phase 1) and a collaboration with GlaxoSmithKline targeting PVRIG (SRF813, preclinical). The company was founded by David S. Grayzel in 2014 and is headquartered in Cambridge, MA.	Health Technology